Label: HEMMOREX-HC- hydrocortisone acetate suppository

  • NDC Code(s): 16477-201-12, 16477-201-24, 16477-201-99
  • Packager: Laser Pharmaceuticals, LLC
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated January 23, 2025

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION
    HEMMOREX-HC™ (hydrocortisone acetate suppositories), 25mg - Rx Only - For Rectal Administration
  • DESCRIPTION:
    Hydrocortisone acetate is a corticosteroid designed chemically as pregn-4-ene 3, 20-dione, 21-(acetyloxy)-11, 17-dihydroxy––(11 β) with the following structural formula: Each rectal suppository ...
  • CLINICAL PHARMACOLOGY:
    In normal subjects, about 26% of hydrocortisone acetate is absorbed when the suppository is applied to the rectum. Absorption of hydrocortisone acetate may vary across abraded or inflamed ...
  • INDICATIONS AND USAGE:
    Hemmorex-HC™ suppositories are indicated for use in inflamed hemorrhoids, post-irradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis; cryptitis; and other ...
  • CONTRAINDICATIONS:
    Hemmorex-HC™ suppositories are contraindicated in those patients having a history of hypersensitivity to hydrocortisone acetate or any of the components.
  • PRECAUTIONS:
    Do not use Hemmorex-HC™ suppositories unless adequate proctologic examination is made. If irritation develops, the product should be discontinued and appropriate therapy instituted. In the ...
  • ADVERSE REACTIONS:
    The following local adverse reactions have been reported with corticosteroid suppositories; burning, itching, irritation, dryness, folliculitis, hypopigmentation, allergic contact dermatitis ...
  • DRUG ABUSE AND DEPENDENCE:
    Drug abuse and dependence have not been reported in patients treated with Hemmorex-HC™ suppositories.
  • OVERDOSAGE:
    If signs and symptoms of systemic overdosage occur, discontinue use.
  • DOSAGE AND ADMINISTRATION:
    For rectal administration. Detach one suppository from strip of suppositories. Remove the wrapper. Avoid excessive handling of the suppository which is designed to melt at body temperature. Insert ...
  • HOW SUPPLIED:
    Hemmorex-HC™ (hydrocortisone acetate suppositories), 25mg are off-white, smooth surfaced and bullet shaped with one pointed end. Box of 12 and 24 suppositories, NDC 16477-201-12 and NDC ...
  • STORAGE:
    Store at 20º-25ºC (68º-77ºF) [See USP Controlled Room Temperature]. Excursions permitted to 15º-30ºC (59º-86ºF). Store away from heat. Protect from freezing.
  • SPL UNCLASSIFIED SECTION
    Manufactured for: Laser Pharmaceuticals, LLC - 1015 Nine North Drive, Ste 400 - Alpharetta, GA 30004 - 770-754-9846 - Rev. 08/24
  • PRINCIPAL DISPLAY PANEL
    label
  • PRINCIPAL DISPLAY PANEL
    100 label
  • INGREDIENTS AND APPEARANCE
    Product Information